Regulatory Spine Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion byJosh SandbergJune 23, 2025
Recon Regulatory Sports Medicine Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early Feasibility Study to a Pivotal Trial of Cutting-Edge Freestyle Knee Implant byTim AllenMay 20, 2025
Recon Regulatory BioPoly® Knee FDA-Approved Clinical Study is Now Published on ClinicalTrials.gov byTim AllenApril 23, 2025
Biologics Spine Cerapedics’ i-FACTOR P-15 Peptide Enhanced Bone Graft, a Trusted Choice in Bone Graft Solutions, Now Approved for Expanded Indications for Use byJosh SandbergSeptember 24, 2024
Regulatory Spine DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease byTim AllenJuly 16, 2024
Regulatory Spine Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator byTim AllenApril 26, 2024
Neuro Regulatory Mainstay Medical Announces Receipt of FDA Approval for MRI Labeling on ReActiv8® Restorative Neurostimulation System™ byJosh SandbergFebruary 12, 2024
Spine Top Stories ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study byJosh SandbergSeptember 26, 2023
Extremities Top Stories Paragon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus™ System for use in Conjunction with the APEX 3D™ Total Ankle Replacement System byJosh SandbergSeptember 11, 2023
Regulatory Spine Top Stories ZimVie Announces FDA Approval for New Mobi-C® Implant byJosh SandbergAugust 10, 2023
